Pilgrim's Pride Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw modest revenue growth but a sharp EBITDA margin decline due to commodity volatility, operational disruptions, and weather impacts. Growth investments and plant upgrades progressed, with strong prepared foods performance offsetting weaker U.S. and Mexico margins.
Fiscal Year 2025
-
Record fiscal 2025 net revenues and Adjusted EBITDA were achieved, with strong U.S. and European performance offsetting volatility in Mexico. Strategic investments in prepared foods and geographic expansion continue, while chicken demand remains robust due to protein affordability and market trends.
-
Q3 2025 saw $4.8B in revenue and $633M adjusted EBITDA, with strong demand and operational gains across U.S., Europe, and Mexico. Strategic investments, portfolio diversification, and stable input costs support a positive outlook, despite ongoing market volatility and export challenges.
-
Q2 2025 saw 4.3% revenue growth and 4.7% higher adjusted EBITDA, driven by strong U.S., Europe, and Mexico performance. Major investments and a $500M special dividend were announced, with robust demand and operational improvements supporting positive outlook.
-
Q1 2025 saw 2.3% revenue growth and a 62% jump in adjusted EBITDA, with strong U.S. and European performance and continued expansion in Mexico. Liquidity remains robust post-dividend, and CapEx is set to ramp up as growth projects progress.
Fiscal Year 2024
-
Q4 and FY2024 saw strong margin expansion and operational improvements across all regions, with U.S., Europe, and Mexico delivering higher profitability. The company maintains a robust balance sheet, is investing in growth and sustainability, and expects continued demand strength in 2025.
-
Q3 2024 saw net revenues rise 5.2% to $4.6B and Adjusted EBITDA more than double year-over-year, driven by strong U.S. and European performance and resilient demand. Margin expansion, operational improvements, and robust liquidity support continued growth and investment.
-
Q2 2024 saw net revenues rise 5.8% to $4.6B and adjusted EBITDA surge 164% to $666M, with margin expansion across all regions. Strong demand, operational efficiencies, and portfolio diversification drove growth, while CapEx guidance was raised to support further innovation and capacity.